Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis

American Journal of Clinical Pathology

Volumn 114, Issue 6, 2000, Pages 860-866

  Banner, B F ^a   Savas, L ^a   Zivny, J ^a   Tortorelli, K ^a   Bonkovsky, H L ^a  

^a University of Massachusetts   (United States)

Author keywords

NASH; Nonalcoholic steatohepatitis; Ubiquitin

Indexed keywords

BIOLOGICAL MARKER; UBIQUITIN;

ADULT; AGED; ARTICLE; CELL DAMAGE; CELL SWELLING; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MALE; PRIORITY JOURNAL; STEATOSIS;

ADULT; AGED; BIOPSY, NEEDLE; FATTY LIVER; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PROTEINS; UBIQUITINS;

EID: 0034525765     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4UBB-BF78-F55V-50KA     Document Type: Article

References (22)

1. Nonalcoholic steatohepatitis
2. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis
3. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
4. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
5. Nonalcoholic steatohepatitis: A study of 49 patients
6. The natural history, of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
7. Nonalcoholic steatohepatitis
8. Nonalcoholic steatohepatitis
9. Nonalcoholic steatohepatitis: An expanded clinical entity
10. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
11. Nonalcoholic fatty liver disease: Assessment of variability in pathologic interpretations
12. Ubiquitin-mediated pathways for intracellular proteolysis
13. Ubiquitin: An immunohistochemical marker of Mallory bodies and alcoholic liver disease
14. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease
15. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes
16. An algorithm for the grading of activity in chronic hepatitis C
17. Iron storage disease
18. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
19. Iron, HFE gene mutation, and non-alcoholic fatty liver disease/insulin resistance syndrome
20. Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
21. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis
22. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C